Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Kane Biotech Inc. Provides Overview of Biofilm Industry, Clinical Development and Growth Drivers in New SNNLive Video Interview with StockNewsNow.com


Posted on: 30 Oct 17

LOS ANGELES, Oct. 30, 2017 (GLOBE NEWSWIRE) -- StockNewsNow.com, The Official MicroCap News Source™, today published an SNNLive Video Interview with Mark Ahrens-Townsend, President and CEO of Kane Biotech Inc. (TSX-V:KNE). Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company was formed in 2001 to study the genetic mechanisms of biofilm formation, which has led to the discovery of novel compounds that inhibit or disrupt biofilms, according to the Company's website (see here: www.kanebiotech.com). The video interview was recorded on Thursday, October 5th, 2017 at The MicroCap Conference 2017 in New York City, NY.

Click the following link to watch the SNNLive Video Interview on StockNewsNow.com:

Kane Biotech Inc. - Biotechnology Company Focused on Developing Applications and Products for their Biofilm Technology

You can follow Stock News Now on FACEBOOKTWITTERLINKEDINYOUTUBE, and STOCKTWITS

Please review important disclosures on our website at: http://stocknewsnow.com/legal.php#disclaimer

About Kane Biotech Inc.
Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms.

The Corporation has a portfolio of biotechnologies, intellectual property (71 patents and patents pending, trade secrets and trademarks) and products developed by the Corporation's own biofilm research expertise and acquired from leading research institutions. StrixNB™, DispersinB®, Aledex®, bluestem™, AloSera™, coactiv+™ and Kane® are trademarks of Kane Biotech Inc. The Corporation is listed on the TSX Venture Exchange under the symbol "KNE".

For more information about Kane Biotech Inc., please visit: www.kanebiotech.com

About StockNewsNow.com
StockNewsNow.com is a microcap financial news portal that features news and insights from the microcap and emerging growth financial community. StockNewsNow.com is a multimedia destination hub for information about microcap and emerging growth public and private companies, market events, news, bulletins, stock quotes, expert commentary and company profiles that feature SNN-produced video like SNNLive CEO video interviews, as well as their latest news and headlines. Users can engage directly and share the information provided through social media.

Follow the companies YOU want to know more about; read and watch content from YOUR favorite microcap, emerging growth financial experts; register to attend financial conferences of YOUR choosing; find microcap and emerging growth financial professionals that YOU may be looking for - all here on StockNewsNow.com.

StockNewsNow.com
info@stocknewsnow.com

SOURCE: StockNewsNow.com

GlobeNewswire
globenewswire.com

Last updated on: 31/10/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.